Morgan Stanley raised the firm’s price target on American Healthcare REIT (AHR) to $29 from $27 and keeps an Overweight rating on the shares after updating estimates to reflect Q3 earnings and mark to market the multiple based on where healthcare peers have traded.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT Announces Quarterly Distribution
- American Healthcare REIT price target raised to $30 from $28 at RBC Capital
- American Healthcare REIT price target raised to $36 from $31 at BofA
- American Healthcare REIT price target raised to $29 from $27 at Truist
- American Healthcare REIT, Inc. Reports Q3 2024 Results